Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Brenner

Showing results (261-270 of 271) with videos related to

Pageof 28
Sort By:
Cell Death & Disease|April 7, 2017
p45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restrictionShrey Kohli, Juliane Hoffmann, Franziska Lochmann, et al.
The New England Journal of Medicine|March 31, 2020
Apixaban for the Treatment of Venous Thromboembolism Associated with CancerGiancarlo Agnelli, Cecilia Becattini, Guy Meyer, et al.
Thrombosis and Haemostasis|August 14, 2018
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio StudyGiancarlo Agnelli, Cecilia Becattini, Rupert Bauersachs, et al.
The Lancet. Haematology|August 30, 2016
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE studyMarjolein P A Brekelmans, Walter Ageno, Ludo F Beenen, et al.
Blood|September 4, 2016
Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblastsShrey Kohli, Satish Ranjan, Juliane Hoffmann, et al.
The New England Journal of Medicine|December 7, 2010
Oral rivaroxaban for symptomatic venous thromboembolism, Rupert Bauersachs, Scott D Berkowitz, et al.
The Lancet. Oncology|June 30, 2022
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19Dominique Farge, Corinne Frere, Jean M Connors, et al.
European Journal of Haematology|February 13, 2026
Platelet and Fibrinogen Dynamics After CAR-T Cell Therapy in Relapsed/Refractory B-Cell Lymphoma May Predict ICANS OnsetHazim Khatib, Amit Parizat, Jabour Halloun, et al.
Thrombosis and Haemostasis|December 7, 2017
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 StudyFrederikus A Klok, Walter Ageno, Stefano Barco, et al.
The New England Journal of Medicine|April 11, 2014
Fibrinolysis for patients with intermediate-risk pulmonary embolismGuy Meyer, Eric Vicaut, Thierry Danays, et al.
Pageof 28

Showing results (261-270 of 271) with videos related to

Sort By:
Pageof 28
Cell Death & Disease|April 7, 2017
p45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restrictionShrey Kohli, Juliane Hoffmann, Franziska Lochmann, et al.
The New England Journal of Medicine|March 31, 2020
Apixaban for the Treatment of Venous Thromboembolism Associated with CancerGiancarlo Agnelli, Cecilia Becattini, Guy Meyer, et al.
Thrombosis and Haemostasis|August 14, 2018
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio StudyGiancarlo Agnelli, Cecilia Becattini, Rupert Bauersachs, et al.
The Lancet. Haematology|August 30, 2016
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE studyMarjolein P A Brekelmans, Walter Ageno, Ludo F Beenen, et al.
Blood|September 4, 2016
Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblastsShrey Kohli, Satish Ranjan, Juliane Hoffmann, et al.
The New England Journal of Medicine|December 7, 2010
Oral rivaroxaban for symptomatic venous thromboembolism, Rupert Bauersachs, Scott D Berkowitz, et al.
The Lancet. Oncology|June 30, 2022
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19Dominique Farge, Corinne Frere, Jean M Connors, et al.
European Journal of Haematology|February 13, 2026
Platelet and Fibrinogen Dynamics After CAR-T Cell Therapy in Relapsed/Refractory B-Cell Lymphoma May Predict ICANS OnsetHazim Khatib, Amit Parizat, Jabour Halloun, et al.
Thrombosis and Haemostasis|December 7, 2017
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 StudyFrederikus A Klok, Walter Ageno, Stefano Barco, et al.
The New England Journal of Medicine|April 11, 2014
Fibrinolysis for patients with intermediate-risk pulmonary embolismGuy Meyer, Eric Vicaut, Thierry Danays, et al.
Pageof 28